Methods for the Derivation and Use of Cardiomyocytes from Human Pluripotent Stem Cells

Methods in Molecular Biology

Volumn 767, Issue , 2011, Pages 419-431

  Zhu, Wei Zhong ^a   Van Biber, Benjamin ^a   Laflamme, Michael A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

activin A; bone morphogenetic protein 4; cardiomyocytes; directed differentiation

Indexed keywords

ACTIVIN; ACTIVIN A; BONE MORPHOGENETIC PROTEIN 4; COLLAGEN; LAMININ; MATRIGEL; PERCOLL; POVIDONE; PROTEOGLYCAN; SILICON DIOXIDE;

ANIMAL; ANIMAL EMBRYO; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CRYOPRESERVATION; CULTURE MEDIUM; CULTURE TECHNIQUE; CYTOLOGY; DENSITY GRADIENT CENTRIFUGATION; DRUG COMBINATION; DRUG EFFECT; FIBROBLAST; HEART MUSCLE CELL; HUMAN; METABOLISM; METHODOLOGY; MOUSE; PLURIPOTENT STEM CELL;

ACTIVINS; ANIMALS; BONE MORPHOGENETIC PROTEIN 4; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELLS, CULTURED; CENTRIFUGATION, DENSITY GRADIENT; COLLAGEN; CRYOPRESERVATION; CULTURE MEDIA, CONDITIONED; DRUG COMBINATIONS; EMBRYO, MAMMALIAN; FIBROBLASTS; HUMANS; LAMININ; MICE; MYOCYTES, CARDIAC; PLURIPOTENT STEM CELLS; POVIDONE; PROTEOGLYCANS; SILICON DIOXIDE;

EID: 80054762880     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-61779-201-4_31     Document Type: Chapter

References (19)

1. Reinecke H, Minami E, Zhu WZ, Laflamme MA (2008) Cardiogenic differentiation and transdifferentiation of progenitor cells. Circ Res. 103: 1058–1071.
2. Zhu WZ, Hauch KD, Xu C, Laflamme MA (2009) Human embryonic stem cells and cardiac repair. Transplant Rev (Orlando) 23: 53–68.
3. Zhu WZ, Santana LF, Laflamme MA (2009) Local control of excitation-contraction coupling in human embryonic stem cell-derived cardiomyocytes. PLoS ONE. 4: e5407.
4. Zhang J, Wilson GF, Soerens AG, Koonce CH, Yu J, et al. (2009) Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res. 104: e30-41.
5. Caspi O, Huber I, Kehat I, Habib M, Arbel G, et al. (2007) Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. J Am Coll Cardiol. 50: 1884–1893.
6. Laflamme MA, Chen KY, Naumova AV, Muskheli V, Fugate JA, et al. (2007) Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol. 25: 1015–1024.
7. van Laake LW, Passier R, Monshouwer-Kloots J, Verkleij AJ, Lips DJ, et al. (2007) Human embryonic stem cell-derived cardiomyocytes survive and mature in the mouse heart and transiently improve function after myocardial infarction. Stem Cell Research. 1: 9–24.
8. Nussbaum J, Minami E, Laflamme MA, Virag JA, Ware CB, et al. (2007) Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. Faseb J. 21: 1345–1357.
9. Swijnenburg RJ, Tanaka M, Vogel H, Baker J, Kofidis T, et al. (2005) Embryonic stem cell immunogenicity increases upon differentiation after transplantation into ischemic myocar-dium. Circulation. 112: I166-172.
10. Xu C, Police S, Rao N, Carpenter MK (2002) Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circ Res. 91: 501–508.
11. Xu C, Inokuma MS, Denham J, Golds K, Kundu P, et al. (2001) Feeder-free growth of undifferentiated human embryonic stem cells. Nat Biotechnol. 19: 971–974.
12. Xu C, Carpenter MK (2003) Human embryonic stem cell-derived cardiomyocytes: Derivation and characterization; Chiu A, Rao MS, editors. Totowa, NJ: Humana Press Inc.
13. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, et al. (1998) Embryonic stem cell lines derived from human blastocysts. Science. 282: 1145–1147.
14. Ludwig TE, Levenstein ME, Jones JM, Berggren WT, Mitchen ER, et al. (2006) Derivation of human embryonic stem cells in defined conditions. Nat Biotechnol. 24: 185–187.
15. Li Y, Powell S, Brunette E, Lebkowski J, Mandalam R (2005) Expansion of human embryonic stem cells in defined serum-free medium devoid of animal-derived products. Biotechnol Bioeng. 91: 688–698.
16. Wang G, Zhang H, Zhao Y, Li J, Cai J, et al. (2005) Noggin and bFGF cooperate to maintain the pluripotency of human embryonic stem cells in the absence of feeder layers. Biochem Biophys Res Commun. 330: 934–942.
17. Wang L, Li L, Menendez P, Cerdan C, Bhatia M (2005) Human embryonic stem cells maintained in the absence of mouse embryonic fibroblasts or conditioned media are capable of hematopoietic development. Blood. 105: 4598–4603.
18. Wang L, Schulz TC, Sherrer ES, Dauphin DS, Shin S, et al. (2007) Self-renewal of human embryonic stem cells requires insulin-like growth factor-1 receptor and ERBB2 receptor signaling. Blood.
19. Sato N, Meijer L, Skaltsounis L, Greengard P, Brivanlou AH (2004) Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat Med. 10: 55–63.